Healthcare technology company providing patient intake and engagement solutions for healthcare providers.
Phreesia, Inc., headquartered in Raleigh, North Carolina, operates as a leading provider of integrated SaaS-based software and payment platforms tailored for the healthcare industry across the United States and Canada. Established in 2005, Phreesia offers its innovative Phreesia Platform, which serves as a comprehensive suite of solutions designed to streamline and optimize the patient intake process.
At the core of Phreesia's offerings is its versatile Phreesia Platform, accessible through various modalities including Phreesia Mobile for patients' mobile devices, Phreesia Dashboard for web-based client management, PhreesiaPads for self-service intake tablets, and Arrivals Kiosks situated on-site. This platform integrates robust features such as automated patient self-registration, insurance verification tools, point-of-sale payment applications, and cost estimation capabilities to enhance the efficiency of healthcare practices.
Phreesia also provides advanced solutions like access management for appointment scheduling, reminders, and referral tracking, as well as clinical support functionalities that facilitate the collection of clinical intake and patient-reported outcome (PRO) data across approximately 25 medical specialties. The platform enables healthcare providers to engage with patients through surveys, announcements, text and email messaging, and health campaigns.
In response to evolving healthcare needs, Phreesia has developed specialized COVID-19 support modules within its platform.s. These modules aid in managing COVID-19 vaccine distribution, identifying vaccine-hesitant patients, conducting self-reported COVID-19 risk assessments, facilitating contactless check-ins for in-person visits, and gathering intake information during telehealth consultations. Phreesia's clientele includes patients, single-specialty practices, multi-specialty groups, health systems, and stakeholders in the pharmaceutical, medical device, and biotechnology sectors, underscoring its pivotal role in modernizing healthcare administration and patient engagement.